Informação sobre produto
SLV-2436 is a small molecule that has been shown to inhibit the PD-L1 protein and is currently being studied for use in cancer treatment. SLV-2436 is an inhibitor of pd-l1, which is an immune checkpoint protein that binds to the B7 family of costimulatory molecules. The interaction of these two proteins inhibits T cell proliferation and activation. SLV-2436 was shown to potentiate tumor regression in mouse models of melanoma, colon carcinoma, and sarcoma. It also showed potent inhibition against hyperproliferative diseases such as rheumatoid arthritis and multiple sclerosis. In addition, SLV-2436 has been shown to have myeloid derived suppressor activity in vitro and may be useful as a conditioning agent prior to bone marrow transplantation or as an adjuvant therapy for other hematologic malignancies.
Propriedades químicas
Consulta técnica sobre: 3D-VID70443 SLV-2436
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.